Eli Lilly Expands Its In Vivo Ambitions, Acquiring Cell Therapy Startup Orna for up to $2.4B – MedCity News
The next frontier for cell therapy is shaping up to be in vivo treatments for autoimmune disease, and Eli Lilly…
The next frontier for cell therapy is shaping up to be in vivo treatments for autoimmune disease, and Eli Lilly…
1. THE SEAMLESS LINKThis strategic alliance between the Global Finance & Technology Network (GFTN) and the Startup Policy Forum (SPF)…
After four decades of doing important work in Bangladesh’s academic landscape, Sunrise Coaching Center is making a comeback. Founded in…
The shutdown of Nigeria-based Okra marks a major moment for Africa’s fintech and crypto future, raising concerns about sustainability, infrastructure,…
Five years after operating as a provider of school management platforms (SMS), Henon Edtech Solutions is circling back to its…